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Abstract 
A 59-year-old female patient presented at the outpatients’ Department of 
Ophthalmology with epiphora, eyelid swelling, and a foreign body feeling in the right 
eye. The symptoms were present for 4 months, and the patient was treated as suffering 
from relapsing conjunctivitis. The slit lamp examination revealed keratitis due to 
exposure, related with the deficient closure of the eyelids. There was a 2 mm difference 
in the readings with the Hertel exophthalmometry examination between the eyes. Her 
medical history was clear, and she was referred for computed tomography of the orbits 
and brain and biochemical examinations (FT3, FT4, and TSH) to investigate the presence 
of an intraorbital mass. FT3 was significantly increased and TSH was accordingly low, 
indicating the diagnosis of Graves’ disease, which presented without other signs and 
symptoms apart from ophthalmopathy. Computed tomography scan excluded the 
diagnosis of an intraorbital mass. Therefore, it is important not to underestimate the 
ocular manifestations of systemic diseases. 
 
Introduction 
Graves’ disease usually affects females, and in 25–50% of the cases coexists with 
ophthalmopathy [1]. Thyroid eye disease is a relatively rare condition, which affects 2.9–
16.0 of cases per 100,000 per year [2]. Here, we describe an interesting case of Graves’ 
ophthalmopathy, which was misdiagnosed and treated as relapsing conjunctivitis.   
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Case Report 
A 59-year-old female patient presented at the outpatients’ Department of Ophthalmology with the 
symptom complex of conjunctival hyperemia, epiphora, irritation, and a foreign body sensation in the 
right eye (fig. 1). She had been examined by multiple ophthalmologists prior to our evaluation, as the 
symptoms were present for 4 months, and she was treated as suffering from relapsing conjunctivitis. 
A full ophthalmic evaluation was performed, and the slit lamp examination revealed keratitis due to 
exposure, which was related to the widening of the interpalpebral fissure and accelerated tear film 
evaporation in the right eye. The other eye was normal, as well as the intraocular pressure bilaterally. 
The patient had no poor aqueous production, and the Schirmer test was normal. There was also a 2 mm 
difference in the readings with the Hertel exophthalmometry examination between the eyes, while a 
sublte deficiency in the supralateral gaze position was revealed in the eye movements examination. In 
addition to this, a detailed medical history was carried out, with a clear result. The patient also 
underwent thorough clinical examination, and it is worthy to mention that she had neither diabetes nor 
other systemic diseases. 
The patient was referred for computed tomography (CT) of the orbits and brain and biochemical 
examinations (FT3, FT4, and TSH) to exclude the presence of an intraorbital mass and investigate the 
cause of exophthalmos. FT3 was significantly increased (4.9 ng/dl, normal ranges: 0.9–1.8 ng/dl) and 
TSH was accordingly low (0.03 mIU, normal ranges: 0.17–4.65 mIU), indicating the diagnosis of 
Graves’ disease, although there was no goiter. CT scan revealed enlargement of the extraocular muscles 
and excluded the diagnosis of an intraorbital mass (fig. 2). The other laboratory findings were all 
normal. Three months later, the ophthalmopathy improved on antithyroid treatment [Thyrostat 5 mg 
(Carbimazole), 3 tablets 3 times/day]. Moreover, artificial tears (Systane Ultra lubricant eye drops, 
Alcon; 1 drop 6 times/day) caused reduction of symptoms, while resolving corneal staining and 
hyperemia. Therefore, the patient suffered from undiagnosed Graves’ disease, without other signs and 
symptoms apart from ophthalmopathy. 
Written informed consent was obtained from the patient. 
Discussion 
The classic symptoms of the thyroid eye disease include eyelid retraction, 
exophthalmos, dysmotility, and diplopia [1–5]. Nevertheless, there are patients who 
present only ocular surface irritation, hyperemia and conjunctivitis [2, 3]. Although these 
latter findings are well established, ocular manifestations are frequently overlooked, and 
diagnosis of thyroid disease is usually made when the classic features manifest. In 
addition to this, thyroid eye disease is often misdiagnosed as allergic or relapsing 
conjunctivitis, as tearing and hyperemia are the predominant features [2, 5]. In such 
cases, the presence of eyelid retraction and restricted eye movements helps to differentiate 
thyroid eye disease from other causes of periorbital edema [2, 3, 5]. Moreover, thyroid 
function tests (FT3, FT4, and TSH) can be helpful in the diagnosis of thyroid 
ophthalmopathy and should be included in the routine work-up. 
In conclusion, it is important not to underestimate the ocular manifestations when 
examining a patient, as potentially serious and systematic conditions may underlie these 
symptoms. Furthermore, early recognition of Graves’ orbitopathy is important, as 
response to medical treatment is dependent on the duration of the disease. 
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Fig. 1. Clinical image of the patient showing the conjunctival hyperemia and exophthalmos. 
 
 
 
Fig. 2. CT excluded an intraorbital mass and revealed enlargement of extraocular muscles. 
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